SAIA, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 6.211
EU - Europa 4.396
AS - Asia 2.572
AF - Africa 385
SA - Sud America 20
OC - Oceania 7
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.593
Nazione #
US - Stati Uniti d'America 6.189
GB - Regno Unito 1.083
IT - Italia 921
CN - Cina 859
SG - Singapore 738
SE - Svezia 630
DE - Germania 585
VN - Vietnam 549
IN - India 261
IE - Irlanda 241
UA - Ucraina 237
RU - Federazione Russa 159
FR - Francia 157
TG - Togo 114
BG - Bulgaria 90
CI - Costa d'Avorio 86
EE - Estonia 85
NG - Nigeria 80
ZA - Sudafrica 79
JO - Giordania 76
CH - Svizzera 65
BE - Belgio 38
FI - Finlandia 36
IR - Iran 28
CA - Canada 22
SC - Seychelles 21
JP - Giappone 16
BR - Brasile 11
AT - Austria 10
NL - Olanda 10
ID - Indonesia 8
KR - Corea 8
RO - Romania 8
HR - Croazia 7
AU - Australia 6
GR - Grecia 5
AR - Argentina 4
DK - Danimarca 4
ES - Italia 4
LT - Lituania 4
MK - Macedonia 4
PL - Polonia 4
TR - Turchia 4
CL - Cile 3
HK - Hong Kong 3
LB - Libano 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
EG - Egitto 2
HU - Ungheria 2
KE - Kenya 2
PK - Pakistan 2
PT - Portogallo 2
SI - Slovenia 2
TH - Thailandia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
CZ - Repubblica Ceca 1
EC - Ecuador 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LU - Lussemburgo 1
MA - Marocco 1
MM - Myanmar 1
MN - Mongolia 1
MY - Malesia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
TW - Taiwan 1
Totale 13.593
Città #
Southend 981
Singapore 660
Fairfield 641
Chandler 631
Ashburn 453
Santa Clara 441
Wilmington 301
Woodbridge 299
Seattle 288
Houston 279
Ann Arbor 268
Princeton 264
Dublin 241
Cambridge 212
Dong Ket 205
Boardman 202
Jacksonville 145
Bologna 135
Lomé 114
Turin 109
Westminster 106
Berlin 99
Padova 93
Nanjing 90
Sofia 89
Abidjan 86
Abeokuta 80
Bremen 79
Amman 76
Beijing 73
New York 73
Milan 68
Bern 56
San Diego 53
Jinan 52
Changsha 44
Shenyang 44
Saint Petersburg 42
Dearborn 41
Brussels 37
Nanchang 37
Hebei 34
Helsinki 34
Rome 31
Shanghai 28
Mülheim 27
Pune 27
Guangzhou 25
Los Angeles 25
Medford 25
Florence 24
Tianjin 23
Zhengzhou 22
Olalla 21
Taizhou 21
Jiaxing 20
Falls Church 19
Mahé 19
Mountain View 19
Des Moines 18
Hangzhou 17
Norwalk 17
Kuban 16
Lanzhou 14
Taiyuan 14
Tokyo 14
Toronto 14
Haikou 13
London 13
Redmond 13
Verona 13
Leawood 12
Paris 12
Fuzhou 11
Ningbo 11
Ardabil 10
Kunming 10
Phoenix 10
San Venanzo 10
Bühl 9
Redwood City 9
Shenzhen 9
Wuhan 9
Jakarta 8
Soliera 8
Zanjan 8
Falkenstein 7
Frankfurt am Main 7
Hefei 7
Naples 7
São Paulo 7
Washington 7
Andover 6
Chengdu 6
Monmouth Junction 6
Napoli 6
Xi'an 6
Foshan 5
Genoa 5
Migliarino 5
Totale 9.140
Nome #
A Comparison Between Coronary Angioplasty and Coronary Artery Bypass Surgery for the Treatment of Unprotected Left Main Coronary Artery Stenosis (the Bologna Registry). 196
[Cognitive and quality of life trajectory after either surgical or transcatheter aortic valve replacement in high-risk patients] 183
L’angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: 5 anni di esperienza in Italia 180
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and clinical outcome. 176
Antithrombotic Management during Percutaneous Mitral Valve Repair with the Mitraclip System in a Patient with Heparin-Induced Thrombocytopenia 174
Clinical comparison of "normal-hours" vs "off-hours" percutaneous coronary interventions for ST-elevation myocardial infarction. 168
Incidence and Outcome of High On-Treatment Platelet Reactivity in Patients With Non-ST Elevation Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention (from the VIP [VerifyNow and Inhibition of Platelet Reactivity] Study) 162
Cognitive functions: Evaluation and changes after transcatheter aortic valve implantation in elderly patients 162
Acute kidney injury following transcatheter aortic valve implantation: incidence, predictors and 1-year clinical outcome 161
Baseline white blood cell count is an independent predictor of long-term cardiovascular mortality in patients with non-ST-segment elevation acute coronary syndrome, but it does not improve the risk classification of the GRACE score. 160
Causes and timing of death during long-term follow-up after transcatheter aortic valve replacement 153
Vascular complications after balloon aortic valvuloplasty in recent years: Incidence and comparison of two hemostatic devices 148
Clinical imaging of the vulnerable plaque in the coronary arteries: new intracoronary diagnostic methods. 145
Balloon aortic valvuloplasty as a bridge-to-decision in high risk patients with aortic stenosis: A new paradigm for the heart team decision making 143
Optimisation of therapeutic strategies for ST-segment elevation acute myocardial infarction: the impact of a territorial network on reperfusion therapy and mortality 142
Angioplastica delle arterie polmonari nel cuore polmonare cronico tromboembolico: un caso clinico paradigmatico 141
Clinical relevance of homocysteine levels in patients receiving coronary stenting for unstable angina. 139
Coexistence of Degenerative Aortic Stenosis and Wild-Type Transthyretin-Related Cardiac Amyloidosis 138
Long-term effectiveness of early administration of glycoprotein IIb/IIIa agents to real-world patients undergoing primary percutaneous interventions: results of a registry study in an ST-elevation myocardial infarction network. 138
Utility of stress perfusion-cardiac magnetic resonance in follow-up of patients undergoing percutaneous coronary interventions of the left main coronary artery 137
Incidence, treatment, and outcome of acute aortic valve regurgitation complicating percutaneous balloon aortic valvuloplasty 136
Diagnostic performance of standard electrocardiogram for prediction of infarct related artery and site of coronary occlusion in unselected STEMI patients undergoing primary percutaneous coronary intervention 136
How many patients with severe symptomatic aortic stenosis excluded for cardiac surgery are eligible for transcatheter heart valve implantation? 134
null 134
Emerging indications, in-hospital and long-term outcome of balloon aortic valvuloplasty in the transcatheter aortic valve implantation era. 134
Cardiac FDG PET/CT is useful to assess the culprit lesion in nonST-segment elevation myocardial infarction (NSTEMI). 132
Is balloon aortic valvuloplasty safe in patients with significant aortic valve regurgitation? 129
Incidence, treatment and outcome of acute coronary syndromes: A community-based study in the era of myocardial infarction networks. 129
Randomized comparative trial of a thin-strut bare metal cobalt-chromium stent versus a sirolimus-eluting stent for coronary revascularization 129
Biolimus-A9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 128
Coronary artery disease and reasonably incomplete coronary revascularization in high-risk patients undergoing transcatheter aortic valve implantation 128
Prognostic significance of shockable and non-shockable cardiac arrest in ST-segment elevation myocardial infarction patients undergoing primary angioplasty 127
Prodromal angina and risk of 2-year cardiac mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous intervention 127
La brachiterapia endocoronarica nei pazienti diabetici con ristenosi intrastent. 125
The role of percutaneous balloon aortic valvuloplasty as a bridge for transcatheter aortic valve implantation. 124
Short- and long-term prognostic significance of ST-segment elevation in lead aVR in patients with non-ST-segment elevation acute coronary syndrome. 124
Safety and efficacy of early aggressive versus cholesterol-driven lipid-lowering strategies in heart transplantation: A pilot, randomized, intravascular ultrasound study. 124
Impact of a territorial ST-segment elevation myocardial infarction network on prognosis of patients with out-of-hospital cardiac arrest. 124
Predictors of complicated athero-thrombotic lesions in non-ST segment acute coronary syndrome. 123
Cardiac FDG PET/CT to Assess the Culprit Lesion during Acute Infarction 122
Differential effect of everolimus on progression of early and late cardiac allograft vasculopathy in current clinical practice. 121
Efficacy and safety of thrombus aspiration in ST-segment elevation myocardial infarction: an updated systematic review and meta-analysis of randomised clinical trials 119
TCT-670 Incidence, Treatment And Outcome Of Acute Aortic Valve Regurgitation Complicating Percutaneous Balloon Aortic Valvuloplasty 117
Lower long-term mortality within a regional system of care for ST-elevation myocardial infarction. 116
Pre-hospital ECG in patients undergoing primary percutaneous interventions within an integrated system of care: reperfusion times and long-term survival benefits. 116
Incidence, prognostic value and management of vascular complications with transfemoral transcatheter aortic valve implantation. 116
Transcatheter aortic valve implantation with a self-expanding nitinol bioprosthesis: prediction of the need for permanent pacemaker using simple baseline and procedural characteristics. 115
Usefulness of prehospital triage in patients with cardiogenic shock complicating ST-elevation myocardial infarction treated with primary percutaneous coronary intervention 115
Relation between thoracic aortic inflammation and features of plaque vulnerability in the coronary tree in patients with non-ST-segment elevation acute coronary syndrome undergoing percutaneous coronary intervention. An FDG-positron emission tomography and optical coherence tomography study 115
Transcatheter Mitral Valve-in-Valve Dislocation: A Rescue Strategy 114
La rete per il trattamento dell’infarto miocardico acuto con sopraslivellamento del tratto ST in Italia. Risultati della rilevazione RETE IMA WEB 113
Early vs. late IIb/IIIa agents administration in primary percutaneous interventions for ST-elevation myocardial infarction: results of a single centre registry 113
Differential Effect of Everolimus and Metabolic Risk Factors on Early vs. Late Progression of Allograft Vasculopathy: Dissecting Two Faces of the Same Disease 113
Interplay of coronary angiography and intravascular ultrasound in predicting long-term outcomes after heart transplantation 113
[Prevalence of degenerative aortic valve stenosis in the elderly: results of a large community-based epidemiological study] 113
Risk of stroke in patients with stable coronary artery disease undergoing percutaneous coronary intervention versus optimal medical therapy: Systematic review and meta-analysis of randomized controlled trials 113
Prognostic significance of mean platelet volume on admission in an unselected cohort of patients with non ST-segment elevation acute coronary syndrome. 113
Randomized comparison between tirofiban and abcximab to promote complete ST-resolution in primary angioplasty: results of the facilitated angioplasty with tirofiban or abcximab (FATA) in ST-elevation myocardial infarction trial 111
Percutaneous mitral valve repair: The last chance for symptoms improvement in advanced refractory chronic heart failure? 111
La qualità di vita dopo impianto transcatetere di valvola aortica: revisione e valutazione critica della letteratura [Quality of life after transcatheter aortic valve implantation: a Comprehensive literature review and critical appraisal] 111
Elevati livelli pre-procedurali della proteina C-reattiva predicono la mortalita a 9 mesi dall'angioplastica del tronco comune non protetto. 110
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 109
Ogni lungo viaggio inizia con un piccolo passo: Il Signor C e la cardiologia interventistica 109
Predictive value of high sensitivity C-reactive protein in patients with ST-elevation myocardial infarction treated with percutaneos coronary intervention 108
Is Pulmonary Artery Pulsatility Index (PAPi) a Predictor of Outcome after Pulmonary Endarterectomy? 106
Long-term effectiveness of early administration of IIb/IIIa agents to high-risk patients undergoing primary percutaneous interventions 106
The safety of drug-eluting stents. 106
Risk of stroke in patients with high on-clopidogrel platelet reactivity to adenosine diphosphate after percutaneous coronary intervention 105
Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with tirofiban or Abciximab [FATA] trial) 104
The role of percutaneous aortic bloon valvuloplasty for severe degenerative aortic valve stenosis in the modern era of interventional cardiology 103
Differential Effects of Everolimus on Early vs. Late Allograft Vasculopathy Progression in Heart Transplant Recipients: a Longitudinal IVUS-Based Study 103
Standard ECG to predict culprit left main disease in unselected patients with non ST-segment elevation acute coronary syndrome 102
How should i treat an unexpected deadlock at the time of transcatheter aortic valve prosthesis implantation? 101
[Bioresorbable vascular scaffolds: clinical experience of the Emilia-Romagna Region, Italy] 101
Management of acute left ventricular dysfunction after primary percutaneous coronary intervention for ST elevation acute myocardial infarction 99
Left ventricular recovery after ST-elevation myocardial infarction in patients treated with primary coronary angioplasty and abciximab or tirofiban 98
Repeated Aortic Balloon Valvuloplasty in Elderly Patients With Aortic Stenosis Who Are Not Candidates for Definitive Treatment 98
Twelve-Month Outcome of Patients with an Established Indication for Oral Anticoagulation Undergoing Coronary Artery Stenting and Stratified by the Baseline Risk of Bleeding. Insights from the Warfarin and Coronary Stenting (War-Stent) Registry 98
Riduzione del tempo di ritardo terapeutico e della mortalità ospedaliera nei pz con STEMI grazie ad un programma di accesso rapido alla PTCA primaria 97
SHORT AND LONG-TERM PROGNOSTIC SIGNIFICANCE OF ST-SEGMENT ELEVATION IN LEAD AVR IN PATIENTS WITH NON-ST-SEGMENT ELEVATION ACUTE CORONARY SYNDROME 97
Biolimus-a9 eluting stent implantion for unprotected left main coronary artery stenosis: 9-month strut coverage as assessed by optical coherence tomography 96
Transcatheter aortic valve implantation for severe autograft regurgitation after Ross operation. 95
Reply: Left Main Extrinsic Compression in Pulmonary Arterial Hypertension: From Identification to Percutaneous Coronary Intervention Optimization 95
Female gender and mortality in ST-segment-elevation myocardial infarction treated with primary PCI 95
One-year outcome of patients eligible to transcatheter aortic valve implantation according to actual treatment 94
Impact of Elective, Uncomplicated Target Lesion Revascularization on Cardiac Mortality After Elective Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery Disease 93
Role of residual acute stent malapposition in percutaneous coronary interventions 92
Effect of fluvastatin on long-term outcome after coronary revascularization with stent implantation. 90
Diagnostic performance of standard electrocardiogramfor prediction of site of coronary occlusion in unselected anterior STEMI patients 90
Influence of C-reactive protein on the effectiveness of IIb/IIIa agents in patients with ST-elevation myocardial infarction treated by percutaneous coronary intervention 87
Predicting and improving outcomes of transcatheter aortic valve replacement in older adults and the elderly 87
null 86
Valve-in-valve technique to manage acute paraprosthetic leak after transcatheter aortic valve implantation. 85
Imaging Myocardium at Risk and Coronary Inflammation in Non-ST-Segment Elevation Myocardial Infarction: Combined Use of FDG PET and Optical Coherence Tomography. 85
[The HEAT-PPCI study] 85
Multi-imaging investigation to evaluate the relationship between serum cystatin c and features of atherosclerosis in Non-ST-Segment elevation acute coronary syndrome 85
Pattern of arterial inflammation and inflammatory markers in people living with HIV compared with uninfected people 85
Therapeutic alternatives in chronic thromboembolic pulmonary hypertension: from pulmonary endarterectomy to balloon pulmonary angioplasty to medical therapy. State of the art from a multidisciplinary team 85
Displacement of calcium nodules of the native valve as a possible cause of left main occlusion following transcatheter aortic valve implantation. 84
Coronary Protection to Prevent Coronary Obstruction During Transcatheter Aortic Valve Replacement: A Multicenter International Registry 81
Totale 11.838
Categoria #
all - tutte 37.296
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.296


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.790 0 0 0 0 0 277 333 348 355 201 107 169
2020/20211.637 335 98 38 72 15 65 31 71 159 84 66 603
2021/20222.336 179 116 132 202 182 119 46 155 80 203 505 417
2022/20233.162 274 444 169 384 255 235 82 188 584 88 278 181
2023/2024944 81 133 43 105 67 259 38 63 24 65 25 41
2024/20252.207 190 544 335 285 644 209 0 0 0 0 0 0
Totale 14.026